Changes in PCSK 9 and apolipoprotein B100 in Niemann–Pick disease after enzyme replacement therapy with olipudase alfa

被引：0

作者：

Bethanie Garside

Jan Hoong Ho

See Kwok

Yifen Liu

Shaishav Dhage

Rachelle Donn

Zohaib Iqbal

Simon A. Jones

Handrean Soran

机构：

[1] University of Manchester,Lipid Research Group, Division of Cardiovascular Sciences

[2] Manchester University NHS Foundation Trust,Cardiovascular Trials Unit, Manchester Royal Infirmary

[3] University of Manchester,Faculty of Biology, Medicine and Health

[4] Manchester University NHS Foundation Trust,Manchester Centre for Genomic Medicine, St Marys Hospital

来源：

Orphanet Journal of Rare Diseases | / 16卷

关键词：

Acid sphingomyelinase deficiency; Apolipoprotein B100; Proprotein convertase subtilisin/klexin type 9; Tumour necrosis factor α; Low density lipoprotein cholesterol; Enzyme replacement therapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 33 条

[31] Development of high sustained IgG antibody titers and corresponding clinical decline in an adolescent with atypical infantile Pompe disease after 11+years on enzyme replacement therapy with alglucosidase alfa
Kim, Katherine H.
Vucko, Erika
Desai, Ankit K.
Kishnani, Priya
Burton, Barbara K.
MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S89 - S89
[32] Changes in left ventricular posterior wall thickness after treatment with enzyme replacement therapy and effect upon the Mainz Severity Score Index in patients with Fabry disease
Holmes, A. M.
Reed, M. C.
Baker, R. J.
Jeevaratnam, P.
Mehta, A. B.
Hughes, D. A.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 : S140 - S140
[33] A case of a 39-year-old man with novel mutation and classic Fabry disease who showed different changes of several biomarkers and speckle tracking after enzyme replacement therapy
Kim, Gee-Hee
MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S84 - S84

← 1 2 3 4 →